This post was originally published on this site

Launching a clinical trial for a drug intended to treat severe asthma during a respiratory pandemic — particularly one that seems to hit people with some types of asthma particularly hard — could be a risky move. Read more.

The post Startup Spotlight: Bullish on its asthma treatment, Kinaset forges ahead in unusual times appeared first on Atlas Venture.